Journal article
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial
JAMA oncology, v 7(9)
01 Sep 2021
PMID: 34086039
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
This nonrandomized trial evaluates the treatment outcomes and safety of pembrolizumab plus concurrent chemoradiation therapy in stage III non–small cell lung cancer.
Metrics
Details
- Title
- Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non–Small Cell Lung Cancer
- Creators
- Salma K. Jabbour - Rutgers, The State University of New JerseyKi Hyeong Lee - Chungbuk National University HospitalNikolaj Frost - Humboldt-Universität zu BerlinValeriy Breder - Russian Cancer Research Center NN BlokhinDariusz M. Kowalski - The Maria Sklodowska-Curie National Research Institute of OncologyTheodore Pollock - Northeastern State UniversityEvgeny Levchenko - Institute of Oncology NN PetrovNoemi Reguart - Hospital Clínic de BarcelonaAlex Martinez-Marti - Vall d'Hebron Hospital UniversitariBaerin Houghton - Port Macquarie Base HospitalJean-Baptiste Paoli - Hôpital privé ClairvalSufia Safina - Republican Clinical Hospital of the Ministry of Health of the Republic of TatarstanKeunchil Park - Samsung Medical CenterTakefumi Komiya - Parkview HealthAmy Sanford - Sanford HealthVishal Boolell - Ballarat Health ServicesHong Liu - Merck & Co., Inc., Rahway, NJ, USA (United States)Ayman Samkari - MSD (Mexico)Steven M. Keller - Merck & Co., Inc., Rahway, NJ, USA (United States)Martin Reck - German Center for Lung Research
- Publication Details
- JAMA oncology, v 7(9)
- Publisher
- American Medical Association
- Grant note
- Merck Sharp & Dohme Corp
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pediatrics
- Web of Science ID
- WOS:000657799300001
- Scopus ID
- 2-s2.0-85108096390
- Other Identifier
- 991021838277004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
Highly Cited Paper
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Oncology